Myeloma Paper of the Day, August 9th, Suggested by Robert Orlowski
Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Serial sFLC measurement in myeloma response and progression assessment adds value to serum M-protein measurements, and can replace 24-h urine collections; in PD pts, 12% had sFLC as the only detectable tumor marker at the 2nd-line.”
Title: Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis
Authors: Elham Askari, Angela Dispenzieri, Francis K. Buadi, Suzanne R. Hayman, Morie A. Gertz, Prashant Kapoor, Wilson Gonsalves, Taxiarchis Kourelis, David Dingli, Rahma Warsame, Nelson Leung, Yi Lin, Eli Muchtar, Joselle Cook, Moritz Binder, Nadine Abdallah, Lisa Hwa, Miriam Hobbs, Amie Fonder, David Murray, Robert. A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar
You can read the Full Article on Blood Cancer Journal.
You can find more posts featuring Robert Orlowski on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023